Leukemia Clinical Trials in Ningbo, Zhejiang
5 recruitingNingbo, Zhejiang, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines630 enrolled155 locationsNCT06943872
Recruiting
Phase 3
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
Chronic Myelomonocytic Leukemia
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.170 enrolled43 locationsNCT06647862
Recruiting
Phase 2Phase 3
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
B-Cell Lymphoblastic Leukemia
Shanghai Jiao Tong University School of Medicine90 enrolled4 locationsNCT06607419
Recruiting
Phase 1Phase 2
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.107 enrolled25 locationsNCT05959694
Recruiting
Phase 1
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
LymphomaLeukemiaMyeloma+1 more
The Affiliated People's Hospital of Ningbo University10 enrolled1 locationNCT05528887